In a genuine effort to protect patients from adverse events, regulatory burdens and research rigidity in clinical trials have increased to a point at which such protection is outweighing the benefits, and actually harming patients who are unable to be involved in clinical trials.
Hagop M. Kantarjian, David J. Stewart, Leonard A. ZwellingJune 6, 2013
The Science and Technology Policy Program reviews the complex federal R&D budget process. Published in July 2011 by Science Progress, a project of the Center for American Progress.
Kirstin R.W. Matthews, Kenneth M. Evans, Neal F. LaneJuly 22, 2011
This article, published in the online journal PLoS ONE, examines the impact of collaboration on publication significance in the United States and the United Kingdom, world leaders in stem cell research with disparate policies. The findings suggest that national stem cell policy differences and regulatory mechanisms driving international stem cell research in both countries did not affect the frequency of international collaborations, or even the countries with which the U.S. and U.K. most often collaborated.
Elaine Howard Ecklund, Kirstin R.W. MatthewsMarch 8, 2011
As the scientific community globalizes, it is increasingly important to understand the effects of international collaboration on the quality and quantity of research produced. While it is generally assumed that international collaboration enhances the quality of research, this phenomenon is not well examined. Stem cell research is unique in that it is both politically charged and a research area that often generates international collaborations, making it an ideal case through which to examine international collaborations.
Kirstin R.W. Matthews, Elaine Howard EcklundMarch 1, 2011
The science advisor to the U.S. president has the opportunity to influence how scientific research is supported by the federal government, as well as the ways in which science and technology can be applied to meet the needs of society.
Neal F. Lane, Kirstin R.W. MatthewsNovember 25, 2009
In March 2009, the James A. Baker III Institute for Public Policy and the Qatar Foundation for Education, Science and Community Development co-hosted a workshop in Doha, Qatar, on stem cell research, policies, and regulations. The event highlighted current stem cell science, as well as stem cell policies and ethics. The discussion focused on policies around the globe and the religious views of embryonic stem cell research from the Christian, Jewish, and Muslim perspectives. The workshop was organized so that outcomes from the event could be relevant to the development of Qatar"s up-and-coming stem cell research. Based on the presentation from the event, the advisory panel for the Baker Institute International Stem Cell Policy Program made a series of recommendations for the new stem cell initiative in Qatar, including the suggestion for outreach to the Qatari community.
This article attempts to explain the so-called turn to the left of several Latin American political systems. There are several "lefts" involved based upon their ideological definitions and their different sociopolitical origins.